• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Unique Cytokine Signature in the Plasma of Patients with Fibromyalgia

B

Bob

Senior Member
Messages
16,455
Location
England (south coast)
USA

Unique Cytokine Signature in the Plasma of Patients with Fibromyalgia
Jamie Sturgill, Elizabeth McGee, and Victoria Menzies
11 March 2014
Journal of Immunology Research
Volume 2014 (2014), Article ID 938576, 5 pages
http://www.hindawi.com/journals/jir/2014/938576/

Full Text Available.

Abstract
Fibromyalgia (FMS) is a chronic pain syndrome with a complex but poorly understood pathogenesis affecting approximately 10 million adults in the United States. The lack of a clear etiology of FMS has limited the effective diagnosis and treatment of this debilitating condition. The objective of this secondary data analysis was to examine plasma cytokine levels in women with FMS using the Bio-Plex Human Cytokine 17-plex Assay. Post hoc analysis of plasma cytokine levels was performed to evaluate patterns that were not specified a priori. Upon examination, patients with FMS exhibited a marked reduction in TH2 cytokines such as IL-4, IL-5, and IL-13. The finding of this pattern of altered cytokine milieu not only supports the role of inflammation in FMS but also may lead to more definitive diagnostic tools for clinicians treating FMS. The TH2 suppression provides strong evidence of immune dysregulation in patients with FMS.
Click to expand...
 
shannah

shannah

Senior Member
Messages
1,429
Does anyone know offhand how this study in FM compares with the cytokines in ME/CFS? Full text also available through link below.

Research Article
Unique Cytokine Signature in the Plasma of Patients with Fibromyalgia
Jamie Sturgill,1,2 Elizabeth McGee,2,3 and Victoria Menzies1,2
1School of Nursing, Virginia Commonwealth University, Richmond, VA 23298, USA
2Institute of Women’s Health, Virginia Commonwealth University, Richmond, VA 23298, USA
3Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont, Burlington, VT 05401, USA

Received 19 November 2013; Revised 28 January 2014; Accepted 5 February 2014; Published 11 March 2014

Academic Editor: Jong-Young Kwak

Copyright © 2014 Jamie Sturgill et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Fibromyalgia (FMS) is a chronic pain syndrome with a complex but poorly understood pathogenesis affecting approximately 10 million adults in the United States. The lack of a clear etiology of FMS has limited the effective diagnosis and treatment of this debilitating condition. The objective of this secondary data analysis was to examine plasma cytokine levels in women with FMS using the Bio-Plex Human Cytokine 17-plex Assay. Post hoc analysis of plasma cytokine levels was performed to evaluate patterns that were not specified a priori. Upon examination, patients with FMS exhibited a marked reduction in cytokines such as IL-4, IL-5, and IL-13. The finding of this pattern of altered cytokine milieu not only supports the role of inflammation in FMS but also may lead to more definitive diagnostic tools for clinicians treating FMS. The suppression provides strong evidence of immune dysregulation in patients with FMS.

http://www.hindawi.com/journals/jir/2014/938576/abs/
 
You must log in or register to reply here.